| Year |
Citation |
Score |
| 2023 |
Manandhar P, Szymczak-Workman AL, Kane LP. Tim-3 Is Not Required for Establishment of CD8+ T Cell Memory to Lymphocytic Choriomeningitis Virus. Journal of Immunology (Baltimore, Md. : 1950). PMID 38108417 DOI: 10.4049/jimmunol.2300401 |
0.455 |
|
| 2023 |
Landy E, Varghese J, Dang V, Workman A, Kane L, Canna S. Complementary HLH Susceptibility Factors Converge on CD8 T-cell Hyperactivation. Blood Advances. PMID 37738167 DOI: 10.1182/bloodadvances.2023010502 |
0.44 |
|
| 2023 |
Tieu R, Zeng Q, Zhao D, Zhang G, Feizi N, Manandhar P, Williams AL, Popp B, Wood-Trageser MA, Demetris AJ, Tso JY, Johnson AJ, Kane LP, Abou-Daya KI, Shlomchik WD, et al. Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15. Science Immunology. 8: eadd8454. PMID 37083450 DOI: 10.1126/sciimmunol.add8454 |
0.489 |
|
| 2023 |
Gocher-Demske AM, Cui J, Szymczak-Workman AL, Vignali KM, Latini JN, Pieklo GP, Kimball JC, Avery L, Cipolla EM, Huckestein BR, Hedden L, Meisel M, Alcorn JF, Kane LP, Workman CJ, et al. IFNγ-induction of T1-like regulatory T cells controls antiviral responses. Nature Immunology. PMID 36928412 DOI: 10.1038/s41590-023-01453-w |
0.514 |
|
| 2022 |
Pagliano O, Morrison RM, Chauvin JM, Banerjee H, Davar D, Ding Q, Tanegashima T, Gao W, Chakka SR, DeBlasio R, Lowin A, Kara K, Ka M, Zidi B, Amin R, ... ... Kane LP, et al. Tim-3 mediates T cell trogocytosis to limit antitumor immunity. The Journal of Clinical Investigation. PMID 35316223 DOI: 10.1172/JCI152864 |
0.453 |
|
| 2021 |
Kane LP. Regulation of Tim-3 function by binding to phosphatidylserine. The Biochemical Journal. 478: 3999-4004. PMID 34813649 DOI: 10.1042/BCJ20210652 |
0.514 |
|
| 2021 |
Banerjee H, Nieves-Rosado H, Kulkarni A, Murter B, McGrath KV, Chandran UR, Chang A, Szymczak-Workman AL, Vujanovic L, Delgoffe GM, Ferris RL, Kane LP. Expression of Tim-3 drives phenotypic and functional changes in Treg cells in secondary lymphoid organs and the tumor microenvironment. Cell Reports. 36: 109699. PMID 34525351 DOI: 10.1016/j.celrep.2021.109699 |
0.466 |
|
| 2021 |
Kataoka S, Manandhar P, Lee J, Workman CJ, Banerjee H, Szymczak-Workman AL, Kvorjak M, Lohmueller J, Kane LP. The costimulatory activity of Tim-3 requires Akt and MAPK signaling and its recruitment to the immune synapse. Science Signaling. 14. PMID 34131021 DOI: 10.1126/scisignal.aba0717 |
0.82 |
|
| 2021 |
Belsky MA, Corredera E, Banerjee H, Moore J, Wang L, Kane LP, Lee SE. Association of Mast Cell Burden and TIM-3 Expression with Recalcitrant Chronic Rhinosinusitis with Nasal Polyps. The Annals of Otology, Rhinology, and Laryngology. 3489421995038. PMID 33576238 DOI: 10.1177/0003489421995038 |
0.398 |
|
| 2020 |
Murter B, Kane LP. Control of T lymphocyte fate decisions by PI3K signaling. F1000research. 9. PMID 33024547 DOI: 10.12688/f1000research.26928.1 |
0.331 |
|
| 2020 |
Ottens K, Schneider J, Kane LP, Satterthwaite AB. PIK3IP1 Promotes Extrafollicular Class Switching in T-Dependent Immune Responses. Journal of Immunology (Baltimore, Md. : 1950). PMID 32887751 DOI: 10.4049/Jimmunol.2000584 |
0.534 |
|
| 2020 |
Poholek CH, Raphael I, Wu D, Revu S, Rittenhouse N, Uche UU, Majumder S, Kane LP, Poholek AC, McGeachy MJ. Noncanonical STAT3 activity sustains pathogenic Th17 proliferation and cytokine response to antigen. The Journal of Experimental Medicine. 217. PMID 32697822 DOI: 10.1084/Jem.20191761 |
0.483 |
|
| 2020 |
Kim HS, Chang CY, Yoon HJ, Kim KS, Koh HS, Kim SS, Lee SJ, Kane LP, Park EJ. Glial TIM-3 modulates immune responses in the brain tumor microenvironment. Cancer Research. PMID 32094297 DOI: 10.1158/0008-5472.Can-19-2834 |
0.423 |
|
| 2019 |
Carroll KL, Avery L, Treat BR, Kane LP, Kinchington PR, Hendricks RL, St Leger AJ. Differential Expression of Immune Checkpoint Molecules on CD8 T Cells Specific for Immunodominant and Subdominant Herpes Simplex Virus 1 Epitopes. Journal of Virology. PMID 31645447 DOI: 10.1128/Jvi.01132-19 |
0.516 |
|
| 2019 |
Nau GJ, Horzempa J, O'Dee D, Brown MJ, Russo BC, Hernandez A, Dillon ST, Cheng J, Kane LP, Sanker S, Hukriede NA. A predicted DXD-motif glycosyltransferase blocks immune activation. Virulence. 10: 643-656. PMID 31314675 DOI: 10.1080/21505594.2019.1631662 |
0.41 |
|
| 2019 |
Hernandez-Mir G, Raphael I, Revu S, Poholek CH, Avery L, Hawse WF, Kane LP, McGeachy MJ. The Alzheimer's Disease-Associated Protein BACE1 Modulates T Cell Activation and Th17 Function. Journal of Immunology (Baltimore, Md. : 1950). PMID 31209103 DOI: 10.4049/Jimmunol.1800363 |
0.592 |
|
| 2018 |
Uche UU, Piccirillo AR, Kataoka S, Grebinoski SJ, D'Cruz LM, Kane LP. PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt. The Journal of Experimental Medicine. PMID 30429249 DOI: 10.1084/Jem.20172018 |
0.568 |
|
| 2018 |
Tilstra JS, Avery L, Menk AV, Gordon RA, Smita S, Kane LP, Chikina M, Delgoffe GM, Shlomchik MJ. Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted. The Journal of Clinical Investigation. PMID 30130253 DOI: 10.1172/Jci120859 |
0.566 |
|
| 2018 |
Corredera E, Phong BL, Moore JA, Kane LP, Lee SE. TIM-3-Expressing Mast Cells Are Present in Chronic Rhinosinusitis with Nasal Polyps. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 194599818774560. PMID 29759032 DOI: 10.1177/0194599818774560 |
0.375 |
|
| 2018 |
Liu Z, McMichael EL, Shayan G, Li J, Chen K, Srivastava RM, Kane LP, Lu B, Ferris RL. Novel effector phenotype of Tim-3+ regulatory T cells leads to enhanced suppressive function in head and neck cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29712685 DOI: 10.1158/1078-0432.Ccr-17-1350 |
0.611 |
|
| 2018 |
Banerjee H, Kane LP. Immune regulation by Tim-3. F1000research. 7: 316. PMID 29560265 DOI: 10.12688/F1000Research.13446.1 |
0.644 |
|
| 2018 |
Avery L, Filderman J, Szymczak-Workman AL, Kane LP. Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion. Proceedings of the National Academy of Sciences of the United States of America. PMID 29463725 DOI: 10.1073/Pnas.1712107115 |
0.592 |
|
| 2017 |
Verma AH, Richardson JP, Zhou C, Coleman BM, Moyes DL, Ho J, Huppler AR, Ramani K, McGeachy MJ, Mufazalov IA, Waisman A, Kane LP, Biswas PS, Hube B, Naglik JR, et al. Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin. Science Immunology. 2. PMID 29101209 DOI: 10.1126/Sciimmunol.Aam8834 |
0.46 |
|
| 2017 |
Jie HB, Srivastava RM, Argiris A, Bauman JE, Kane LP, Ferris RL. Increased PD-1+ and TIM-3+ TILs during cetuximab therapy inversely correlates with response in head and neck cancer patients. Cancer Immunology Research. PMID 28408386 DOI: 10.1158/2326-6066.Cir-16-0333 |
0.426 |
|
| 2017 |
Du W, Yang M, Turner A, Xu C, Ferris RL, Huang J, Kane LP, Lu B. TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action. International Journal of Molecular Sciences. 18. PMID 28300768 DOI: 10.3390/Ijms18030645 |
0.474 |
|
| 2017 |
Shayan G, Srivastava R, Li J, Schmitt N, Kane LP, Ferris RL. Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer. Oncoimmunology. 6: e1261779. PMID 28197389 DOI: 10.1080/2162402X.2016.1261779 |
0.37 |
|
| 2017 |
Montecalvo A, Watkins SC, Orange J, Kane LP. Inducible turnover of optineurin regulates T cell activation. Molecular Immunology. 85: 9-17. PMID 28192730 DOI: 10.1016/J.Molimm.2017.01.027 |
0.517 |
|
| 2016 |
Phong B, Kane LP. Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies. F1000research. 5: 251. PMID 30023044 DOI: 10.12688/F1000Research.8132.2 |
0.548 |
|
| 2016 |
Phong B, Avery L, Menk AV, Delgoffe GM, Kane LP. Cutting Edge: Murine Mast Cells Rapidly Modulate Metabolic Pathways Essential for Distinct Effector Functions. Journal of Immunology (Baltimore, Md. : 1950). PMID 27974455 DOI: 10.4049/Jimmunol.1601150 |
0.438 |
|
| 2016 |
Li J, Shayan G, Avery L, Jie HB, Gildener-Leapman N, Schmitt N, Lu BF, Kane LP, Ferris RL. Tumor-infiltrating Tim-3(+) T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. Oncoimmunology. 5: e1200778. PMID 27853635 DOI: 10.1080/2162402X.2016.1200778 |
0.475 |
|
| 2016 |
Way EE, Trevejo-Nunez G, Kane LP, Steiner BH, Puri KD, Kolls JK, Chen K. Dose-Dependent Suppression of Cytokine production from T cells by a Novel Phosphoinositide 3-Kinase Delta Inhibitor. Scientific Reports. 6: 30384. PMID 27461849 DOI: 10.1038/Srep30384 |
0.54 |
|
| 2015 |
Phong BL, Avery L, Sumpter TL, Gorman JV, Watkins SC, Colgan JD, Kane LP. Tim-3 enhances FcεRI-proximal signaling to modulate mast cell activation. The Journal of Experimental Medicine. PMID 26598760 DOI: 10.1084/Jem.20150388 |
0.658 |
|
| 2015 |
Hawse WF, Sheehan RP, Miskov-Zivanov N, Menk AV, Kane LP, Faeder JR, Morel PA. Cutting Edge: Differential Regulation of PTEN by TCR, Akt, and FoxO1 Controls CD4+ T Cell Fate Decisions. Journal of Immunology (Baltimore, Md. : 1950). 194: 4615-9. PMID 25855357 DOI: 10.4049/Jimmunol.1402554 |
0.547 |
|
| 2015 |
Li J, Jie HB, Lei Y, Gildener-Leapman N, Trivedi S, Green T, Kane LP, Ferris RL. PD-1/SHP-2 inhibits Tc1/Th1 phenotypic responses and the activation of T cells in the tumor microenvironment. Cancer Research. 75: 508-18. PMID 25480946 DOI: 10.1158/0008-5472.Can-14-1215 |
0.447 |
|
| 2014 |
Kane LP. Antigen receptor kinase two-step. Journal of Immunology (Baltimore, Md. : 1950). 193: 4277-8. PMID 25326544 DOI: 10.4049/Jimmunol.1402287 |
0.421 |
|
| 2014 |
Pawaria S, Ramani K, Maers K, Liu Y, Kane LP, Levesque MC, Biswas PS. Complement component C5a permits the coexistence of pathogenic Th17 cells and type I IFN in lupus. Journal of Immunology (Baltimore, Md. : 1950). 193: 3288-95. PMID 25149466 DOI: 10.4049/Jimmunol.1401322 |
0.379 |
|
| 2014 |
Ferris RL, Lu B, Kane LP. Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion. Journal of Immunology (Baltimore, Md. : 1950). 193: 1525-30. PMID 25086175 DOI: 10.4049/Jimmunol.1400557 |
0.619 |
|
| 2014 |
Hamilton KS, Phong B, Corey C, Cheng J, Gorentla B, Zhong X, Shiva S, Kane LP. T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10. Science Signaling. 7: ra55. PMID 24917592 DOI: 10.1126/Scisignal.2005169 |
0.604 |
|
| 2014 |
Cheng J, Hamilton KS, Kane LP. Phosphorylation of Carma1, but not Bcl10, by Akt regulates TCR/CD28-mediated NF-κB induction and cytokine production. Molecular Immunology. 59: 110-6. PMID 24548923 DOI: 10.1016/J.Molimm.2014.01.011 |
0.432 |
|
| 2014 |
Lee CJ, Kane LP. Expression and function of TIM-3, a potential therapeutic target in acute myeloid leukemia. Journal of Clinical Oncology. 32: 7095-7095. DOI: 10.1200/Jco.2014.32.15_Suppl.7095 |
0.431 |
|
| 2013 |
Cheng J, Kane LP. Global identification of genes and pathways regulated by Akt during activation of T helper cells. F1000research. 2: 109. PMID 24627779 DOI: 10.12688/F1000Research.2-109.V2 |
0.532 |
|
| 2013 |
Miskov-Zivanov N, Turner MS, Kane LP, Morel PA, Faeder JR. The duration of T cell stimulation is a critical determinant of cell fate and plasticity. Science Signaling. 6: ra97. PMID 24194584 DOI: 10.1126/Scisignal.2004217 |
0.589 |
|
| 2013 |
Roth CG, Garner K, Eyck ST, Boyiadzis M, Kane LP, Craig FE. TIM3 expression by leukemic and non-leukemic myeloblasts. Cytometry. Part B, Clinical Cytometry. 84: 167-72. PMID 23554257 DOI: 10.1002/Cyto.B.21080 |
0.438 |
|
| 2012 |
Lin J, Chen L, Kane LP. Murine Tim-1 is excluded from the immunological synapse. F1000research. 1: 10. PMID 24627760 DOI: 10.12688/F1000Research.1-10.V2 |
0.623 |
|
| 2012 |
DeFrances MC, Debelius DR, Cheng J, Kane LP. Inhibition of T-cell activation by PIK3IP1. European Journal of Immunology. 42: 2754-9. PMID 22706993 DOI: 10.1002/Eji.201141653 |
0.596 |
|
| 2012 |
Kane LP. Correction: T Cell Ig and Mucin Domain Proteins and Immunity Journal of Immunology. 189: 4695-4695. DOI: 10.4049/Jimmunol.1290065 |
0.547 |
|
| 2011 |
Lee J, Phong B, Egloff AM, Kane LP. TIM polymorphisms--genetics and function. Genes and Immunity. 12: 595-604. PMID 22048452 DOI: 10.1038/Gene.2011.75 |
0.726 |
|
| 2011 |
Cheng J, Phong B, Wilson DC, Hirsch R, Kane LP. Akt fine-tunes NF-κB-dependent gene expression during T cell activation. The Journal of Biological Chemistry. 286: 36076-85. PMID 21862580 DOI: 10.1074/Jbc.M111.259549 |
0.52 |
|
| 2011 |
Lee J, Su EW, Zhu C, Hainline S, Phuah J, Moroco JA, Smithgall TE, Kuchroo VK, Kane LP. Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways. Molecular and Cellular Biology. 31: 3963-74. PMID 21807895 DOI: 10.1128/Mcb.05297-11 |
0.737 |
|
| 2011 |
Cheng J, Montecalvo A, Kane LP. Regulation of NF-κB induction by TCR/CD28. Immunologic Research. 50: 113-7. PMID 21717079 DOI: 10.1007/S12026-011-8216-Z |
0.54 |
|
| 2011 |
Su EW, Bi S, Kane LP. Galectin-9 regulates T helper cell function independently of Tim-3. Glycobiology. 21: 1258-65. PMID 21187321 DOI: 10.1093/Glycob/Cwq214 |
0.785 |
|
| 2010 |
Kane LP. T cell Ig and mucin domain proteins and immunity. Journal of Immunology (Baltimore, Md. : 1950). 184: 2743-9. PMID 20200285 DOI: 10.4049/Jimmunol.0902937 |
0.566 |
|
| 2010 |
Hu W, Nessler S, Hemmer B, Eagar TN, Kane LP, Leliveld SR, Müller-Schiffmann A, Gocke AR, Lovett-Racke A, Ben LH, Hussain RZ, Breil A, Elliott JL, Puttaparthi K, Cravens PD, et al. Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling. Brain : a Journal of Neurology. 133: 375-88. PMID 20145049 DOI: 10.1093/Brain/Awp298 |
0.57 |
|
| 2009 |
Turner MS, Kane LP, Morel PA. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion. Journal of Immunology (Baltimore, Md. : 1950). 183: 4895-903. PMID 19801514 DOI: 10.4049/Jimmunol.0901459 |
0.506 |
|
| 2009 |
Windish HP, Lin PL, Mattila JT, Green AM, Onuoha EO, Kane LP, Flynn JL. Aberrant TGF-beta signaling reduces T regulatory cells in ICAM-1-deficient mice, increasing the inflammatory response to Mycobacterium tuberculosis. Journal of Leukocyte Biology. 86: 713-25. PMID 19454651 DOI: 10.1189/Jlb.1208740 |
0.443 |
|
| 2008 |
Su EW, Lin JY, Kane LP. TIM-1 and TIM-3 proteins in immune regulation. Cytokine. 44: 9-13. PMID 18706830 DOI: 10.1016/J.Cyto.2008.06.013 |
0.782 |
|
| 2008 |
Sasaki K, Zhao X, Pardee AD, Ueda R, Fujita M, Sehra S, Kaplan MH, Kane LP, Okada H, Storkus WJ. Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo. Journal of Immunology (Baltimore, Md. : 1950). 181: 104-8. PMID 18566374 DOI: 10.4049/Jimmunol.181.1.104 |
0.505 |
|
| 2008 |
de Souza AJ, Oak JS, Jordanhazy R, DeKruyff RH, Fruman DA, Kane LP. T cell Ig and mucin domain-1-mediated T cell activation requires recruitment and activation of phosphoinositide 3-kinase. Journal of Immunology (Baltimore, Md. : 1950). 180: 6518-26. PMID 18453570 DOI: 10.4049/Jimmunol.180.10.6518 |
0.617 |
|
| 2007 |
Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, Lei C, Chandwaskar R, Karman J, Su EW, Hirashima M, Bruce JN, Kane LP, Kuchroo VK, Hafler DA. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science (New York, N.Y.). 318: 1141-3. PMID 18006747 DOI: 10.1126/Science.1148536 |
0.777 |
|
| 2007 |
Kane LP. TIM family proteins and autoimmunity. Autoimmunity. 40: 405-8. PMID 17729033 DOI: 10.1080/08916930701464871 |
0.522 |
|
| 2006 |
de Souza AJ, Kane LP. Immune regulation by the TIM gene family. Immunologic Research. 36: 147-55. PMID 17337775 DOI: 10.1385/Ir:36:1:147 |
0.554 |
|
| 2006 |
Knickelbein JE, de Souza AJ, Tosti R, Narayan P, Kane LP. Cutting edge: inhibition of T cell activation by TIM-2. Journal of Immunology (Baltimore, Md. : 1950). 177: 4966-70. PMID 17015678 DOI: 10.4049/Jimmunol.177.8.4966 |
0.597 |
|
| 2006 |
Narayan P, Holt B, Tosti R, Kane LP. CARMA1 is required for Akt-mediated NF-kappaB activation in T cells. Molecular and Cellular Biology. 26: 2327-36. PMID 16508008 DOI: 10.1128/Mcb.26.6.2327-2336.2006 |
0.515 |
|
| 2005 |
de Souza AJ, Oriss TB, O'malley KJ, Ray A, Kane LP. T cell Ig and mucin 1 (TIM-1) is expressed on in vivo-activated T cells and provides a costimulatory signal for T cell activation. Proceedings of the National Academy of Sciences of the United States of America. 102: 17113-8. PMID 16284246 DOI: 10.1073/Pnas.0508643102 |
0.659 |
|
| 2005 |
Kane LP, Watkins SC. Dynamic regulation of Tec kinase localization in membrane-proximal vesicles of a T cell clone revealed by total internal reflection fluorescence and confocal microscopy. The Journal of Biological Chemistry. 280: 21949-54. PMID 15817477 DOI: 10.1074/Jbc.M412913200 |
0.555 |
|
| 2004 |
Kane LP, Mollenauer MN, Weiss A. A proline-rich motif in the C terminus of Akt contributes to its localization in the immunological synapse. Journal of Immunology (Baltimore, Md. : 1950). 172: 5441-9. PMID 15100285 DOI: 10.4049/Jimmunol.172.9.5441 |
0.435 |
|
| 2004 |
Andres PG, Howland KC, Nirula A, Kane LP, Barron L, Dresnek D, Sadra A, Imboden J, Weiss A, Abbas AK. Distinct regions in the CD28 cytoplasmic domain are required for T helper type 2 differentiation. Nature Immunology. 5: 435-42. PMID 15004555 DOI: 10.1038/Ni1044 |
0.517 |
|
| 2004 |
Tomlinson MG, Kane LP, Su J, Kadlecek TA, Mollenauer MN, Weiss A. Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec. Molecular and Cellular Biology. 24: 2455-66. PMID 14993283 DOI: 10.1128/Mcb.24.6.2455-2466.2004 |
0.627 |
|
| 2003 |
Kane LP, Weiss A. The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunological Reviews. 192: 7-20. PMID 12670391 DOI: 10.1034/J.1600-065X.2003.00008.X |
0.521 |
|
| 2002 |
Kane LP, Mollenauer MN, Xu Z, Turck CW, Weiss A. Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription. Molecular and Cellular Biology. 22: 5962-74. PMID 12138205 DOI: 10.1128/Mcb.22.16.5962-5974.2002 |
0.395 |
|
| 2002 |
Xu Z, Stokoe D, Kane LP, Weiss A. The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 13: 285-96. PMID 12133897 |
0.423 |
|
| 2002 |
Kane LP, Lin J, Weiss A. It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation. Trends in Immunology. 23: 413-20. PMID 12133805 DOI: 10.1016/S1471-4906(02)02264-0 |
0.464 |
|
| 2001 |
Avota E, Avots A, Niewiesk S, Kane LP, Bommhardt U, Meulen Vt, Schneider-Schaulies S. Disruption of Akt kinase activation is important for immunosuppression induced by measles virus Nature Medicine. 7: 725-731. PMID 11385511 DOI: 10.1038/89106 |
0.505 |
|
| 2001 |
Kane LP, Andres PG, Howland KC, Abbas AK, Weiss A. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nature Immunology. 2: 37-44. PMID 11135576 DOI: 10.1038/83144 |
0.418 |
|
| 2000 |
Hayden-Martinez K, Kane LP, Hedrick SM. Effects of a constitutively active form of calcineurin on T cell activation and thymic selection. Journal of Immunology (Baltimore, Md. : 1950). 165: 3713-21. PMID 11034376 DOI: 10.4049/Jimmunol.165.7.3713 |
0.548 |
|
| 2000 |
Kane LP, Lin J, Weiss A. Signal transduction by the TCR for antigen. Current Opinion in Immunology. 12: 242-9. PMID 10781399 DOI: 10.1016/S0952-7915(00)00083-2 |
0.516 |
|
| 2000 |
Bui JD, Calbo S, Hayden-Martinez K, Kane LP, Gardner P, Hedrick SM. A role for CaMKII in T cell memory. Cell. 100: 457-67. PMID 10693762 DOI: 10.1016/S0092-8674(00)80681-9 |
0.489 |
|
| 1999 |
Kane LP, Shapiro VS, Stokoe D, Weiss A. Induction of NF-κB by the Akt/PKB kinase Current Biology. 9: 601-604. PMID 10359702 DOI: 10.1016/S0960-9822(99)80265-6 |
0.457 |
|
| 1998 |
Yablonski D, Kane LP, Qian D, Weiss A. A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK The Embo Journal. 17: 5647-5657. PMID 9755165 DOI: 10.1093/Emboj/17.19.5647 |
0.459 |
|
| 1996 |
Page DM, Kane LP, Onami TM, Hedrick SM. Cellular and biochemical requirements for thymocyte negative selection. Seminars in Immunology. 8: 69-82. PMID 8920242 DOI: 10.1006/Smim.1996.0010 |
0.492 |
|
| 1994 |
Vasquez NJ, Kane LP, Hedrick SM. Intracellular signals that mediate thymic negative selection. Immunity. 1: 45-56. PMID 7889398 DOI: 10.1016/1074-7613(94)90008-6 |
0.551 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2011 |
Lin J, Kane LP. Are TIM proteins involved in asthma development or pathology? Clinical and Experimental Allergy : Journal of the British Society For Allergy and Clinical Immunology. 41: 917-9. PMID 21623966 DOI: 10.1111/J.1365-2222.2011.03771.X |
0.295 |
|
| 2010 |
Ho AW, Shen F, Conti HR, Patel N, Childs EE, Peterson AC, Hernández-Santos N, Kolls JK, Kane LP, Ouyang W, Gaffen SL. IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. Journal of Immunology (Baltimore, Md. : 1950). 185: 1063-70. PMID 20554964 DOI: 10.4049/Jimmunol.0903739 |
0.265 |
|
| 2010 |
Ho AW, Shen F, Conti HR, Patel N, Peterson A, Hernández-Santos N, K. Kolls J, Kane L, Ouyang W, Childs EE, Gaffen SL. SS2-4 Molecular and cellular contributions of IL-17RC to IL-17 signaling and host defense against fungal infections Cytokine. 52: 13-14. DOI: 10.1016/J.Cyto.2010.07.059 |
0.259 |
|
| 2023 |
Nieves-Rosado HM, Jacobs JL, Naqvi A, Mellors JW, Macatangay BJ, Kane LP. Tim-3 signaling contributes to the suppressive capacity of Treg from people with HIV on antiretroviral therapy. Journal of Leukocyte Biology. PMID 37350502 DOI: 10.1093/jleuko/qiad068 |
0.252 |
|
| 1973 |
Wharam MD, Phillips TL, Kane L, Utley JF. Response of a murine solid tumor to in vivo combined chemotherapy and irradiation Radiology. 109: 451-455. PMID 4126375 DOI: 10.1148/109.2.451 |
0.231 |
|
| 1973 |
Phillips TL, Kane L, Utley JF. Radioprotection of tumor and normal tissues by thiophosphate compounds Cancer. 32: 528-535. PMID 4199352 DOI: 10.1002/1097-0142(197309)32:3<528::Aid-Cncr2820320303>3.0.Co;2-C |
0.215 |
|
| 2016 |
Ager C, Reilley M, Nicholas C, Bartkowiak T, Jaiswal A, Curran M, Albershardt TC, Bajaj A, Archer JF, Reeves RS, Ngo LY, Berglund P, ter Meulen J, Denis C, Ghadially H, ... ... Kane LP, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0173-6 |
0.204 |
|
| 2013 |
Kane LP. Publishing in the 21st Century F1000research. 4. DOI: 10.7490/F1000Research.1093146.1 |
0.192 |
|
| 2017 |
Cruz JA, Childs EE, Amatya N, Garg AV, Beyaert R, Kane LP, Aneskievich BJ, Ma A, Gaffen SL. Interleukin-17 signaling triggers degradation of the constitutive NF-κB inhibitor ABIN-1. Immunohorizons. 1: 133-141. PMID 30761389 DOI: 10.4049/immunohorizons.1700035 |
0.186 |
|
| Hide low-probability matches. |